Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

0.8760
+0.04455.35%
Post-market: 0.8381-0.0379-4.33%16:06 EDT
Volume:119.89K
Turnover:101.34K
Market Cap:13.18M
PE:-2.09
High:0.8760
Open:0.8200
Low:0.8060
Close:0.8315
Loading ...
May 17, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
Apr 27, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Major Issues Report

8-K - Current report
Nov 24, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 08, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K - Current report
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933